Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy

Medicine ◽

10.1097/md.0000000000027832 ◽

2021 ◽

Vol 100 (49) ◽

pp. e27832

Author(s):

Ikuko Hirai ◽

Keiji Tanese ◽

Keitaro Fukuda ◽

Takayuki Fusumae ◽

Yoshio Nakamura ◽

...

Keyword(s):

Imatinib Mesylate ◽

Standard Therapy

Download Full-text

Implications of imatinib mesylate for hematopoietic stem cell transplantation

Seminars in Hematology ◽

10.1053/shem.2001.27081 ◽

2001 ◽

Vol 38 (3, Suppl 8) ◽

pp. 28-34 ◽

Author(s):

John Goldman

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Imatinib Mesylate ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem

Download Full-text

Initial experiences utilizing perfusion CT in the follow-up of patients with gastrointestinal stromal tumors under imatinib mesylate treatment

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ◽

10.1055/s-0028-1085909 ◽

2008 ◽

Vol 180 (09) ◽

Author(s):

F Berger ◽

M Hittinger ◽

M Schlemmer ◽

T Saam ◽

K Nikolaou ◽

...

Keyword(s):

Imatinib Mesylate ◽

Gastrointestinal Stromal Tumors ◽

Perfusion Ct ◽

Download Full-text

Multimodal immunotherapy integrated into standard therapy for GBM: learning from clinical practice

10.1055/s-0038-1675280 ◽

2018 ◽

Author(s):

SW Van Gool ◽

J Makalowski ◽

O Feyen ◽

L Fiedler ◽

L Prix ◽

...

Keyword(s):

Clinical Practice ◽

Standard Therapy

Download Full-text

SINGLE OTSC CLIP IS SUPERIOR COMPARED TO STANDARD THERAPY FOR ACUTE UPPER GI BLEEDING IN LARGE UK SERIES- IS IT TIME TO CHANGE?

10.1055/s-0040-1704181 ◽

2020 ◽

Author(s):

I Rahman ◽

P Duarte ◽

T Hollingworth ◽

P Boger ◽

P Patel

Keyword(s):

Standard Therapy ◽

Gi Bleeding ◽

Upper Gi Bleeding ◽

Download Full-text

Therapeutic interest of Imatinib Mesylate in osteosarcoma

Bone Abstracts ◽

10.1530/boneabs.1.pp141 ◽

2013 ◽

Author(s):

Berengere Gobin ◽

Gatien Moriceau ◽

Benjamin Ory ◽

Regis Brion ◽

Francoise Redini ◽

...

Keyword(s):

Imatinib Mesylate

Download Full-text

04 / A split-mouth randomized clinical trial: standard therapy vs ultrasonic therapy and ozonetherapy

10.26226/morressier.5ac383162afeeb00097a435f ◽

2018 ◽

Author(s):

Carolina Maiorani

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Standard Therapy ◽

Ultrasonic Therapy

Download Full-text

Study of Pembrolizumab (MK-3475) Versus Investigator's Choice Standard Therapy for Participants With Advanced Esophageal/Esophagogastric Junction Carcinoma That Progressed After First-Line Therapy (MK-3475-181/KEYNOTE-181)-China Extension Study

Case Medical Research ◽

10.31525/ct1-nct03933449 ◽

2019 ◽

Author(s):

Keyword(s):

Standard Therapy ◽

Esophagogastric Junction ◽

Extension Study ◽

First Line Therapy ◽

Line Therapy ◽

Esophagogastric Junction Carcinoma

Download Full-text

Faculty Opinions recommendation of Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1033567.489987 ◽

2006 ◽

Author(s):

Gerhard Ehninger

Keyword(s):

Imatinib Mesylate ◽

Therapeutic Agent

Download Full-text

Faculty Opinions recommendation of Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1033567.388749 ◽

2006 ◽

Author(s):

John Kyriakis

Keyword(s):

Imatinib Mesylate ◽

Therapeutic Agent

Download Full-text

Faculty Opinions recommendation of Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1105194.561388 ◽

2008 ◽

Author(s):

Michael Deininger ◽

Paul La Rosée

Keyword(s):

Chronic Myeloid Leukemia ◽

Imatinib Mesylate ◽

Interferon Alpha ◽

Myeloid Leukemia ◽

Chronic Phase ◽

Long Term Follow Up ◽

Interferon Alpha Treatment

Download Full-text